Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience
- PMID: 32976875
- DOI: 10.1016/j.radonc.2020.09.024
Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience
Abstract
Background and purpose: Daily online adaptation of the clinical target volume (CTV) using MR-guided radiotherapy enables margin reduction of the planning target volume (PTV). This study describes the implementation and initial experience of MR-guided radiotherapy on the 1.5T MR-linac and evaluates treatment time, patient compliance, and target coverage, including an initial assessment of margin reduction.
Materials and methods: Patients were treated on a 1.5T MR-linac (7MV, FFF). At each fraction a 3D T2 weighted (T2w) MR-sequence was acquired on which the CTV was adapted after a deformable registration of the contours from the pre-planning CT scan. Based on the new contours a full online replanning was done after which a new 3D T2w MR-sequence was acquired for position verification. A 5 field Intensity Modulated Radiotherapy (IMRT) plan was delivered.
Results: Forty-three patients with rectal cancer were treated with 25 Gy in 5 fractions of which 18 with reduced margins. In total, 204 of 215 fractions were delivered on the MR-linac all of which obtained a clinically acceptable treatment plan. Median in-room time per fraction was 48 min (interquartile range 8). No fractions were canceled or interrupted because of patient intolerance. CTV coverage after margin reduction was good on all post-treatment scans but one due to passing gas.
Conclusion: MR-guided radiotherapy using daily full online recontouring and replanning on a 1.5T MR-linac for rectal cancer is feasible and currently takes about 48 min per fraction.
Keywords: Image-guided radiation; Magnetic resonance imaging; Neoadjuvant therapy; Radiotherapy; Rectal cancer.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Comment in
-
Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al.Radiother Oncol. 2021 May;158:244-245. doi: 10.1016/j.radonc.2021.02.041. Epub 2021 Mar 7. Radiother Oncol. 2021. PMID: 33691186 No abstract available.
Similar articles
-
Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.Radiat Oncol. 2021 Jul 23;16(1):136. doi: 10.1186/s13014-021-01866-7. Radiat Oncol. 2021. PMID: 34301300 Free PMC article.
-
Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers.Radiat Oncol. 2024 Sep 2;19(1):114. doi: 10.1186/s13014-024-02508-4. Radiat Oncol. 2024. PMID: 39218934 Free PMC article.
-
Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study.Clin Oncol (R Coll Radiol). 2023 Feb;35(2):e135-e142. doi: 10.1016/j.clon.2022.10.008. Epub 2022 Nov 3. Clin Oncol (R Coll Radiol). 2023. PMID: 36336579
-
[Image-guided radiotherapy contribution and patient setup for anorectal cancer treatment].Cancer Radiother. 2018 Oct;22(6-7):622-630. doi: 10.1016/j.canrad.2018.06.019. Epub 2018 Aug 22. Cancer Radiother. 2018. PMID: 30143462 Review. French.
-
[Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].Radiologe. 2021 Sep;61(9):839-845. doi: 10.1007/s00117-021-00882-8. Epub 2021 Jul 23. Radiologe. 2021. PMID: 34297139 Free PMC article. Review. German.
Cited by
-
Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial.BMJ Open. 2023 Jun 15;13(6):e065010. doi: 10.1136/bmjopen-2022-065010. BMJ Open. 2023. PMID: 37321815 Free PMC article.
-
Evaluating the effect of higher Monte Carlo statistical uncertainties on accumulated doses after daily adaptive fractionated radiotherapy in prostate cancer.Phys Imaging Radiat Oncol. 2024 Sep 5;32:100636. doi: 10.1016/j.phro.2024.100636. eCollection 2024 Oct. Phys Imaging Radiat Oncol. 2024. PMID: 39295957 Free PMC article.
-
MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation.Front Oncol. 2021 Mar 30;11:619852. doi: 10.3389/fonc.2021.619852. eCollection 2021. Front Oncol. 2021. PMID: 33859937 Free PMC article.
-
Evaluation of the clinical feasibility of cone-beam computed tomography guided online adaption for simulation-free palliative radiotherapy.Phys Imaging Radiat Oncol. 2023 Aug 31;28:100490. doi: 10.1016/j.phro.2023.100490. eCollection 2023 Oct. Phys Imaging Radiat Oncol. 2023. PMID: 37705690 Free PMC article.
-
Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.Radiat Oncol. 2021 Jul 23;16(1):136. doi: 10.1186/s13014-021-01866-7. Radiat Oncol. 2021. PMID: 34301300 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical